Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Talis Biomedical's Business Segments
Talis Biomedical's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
-
Talis Biomedical does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - FY
- Grant91.7%
- Product8.3%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Grant | $ 1 | 91.7% |
| Product | $ 0 | 8.3% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Talis Biomedical
Talis Biomedical Corporation is a cutting-edge biotechnology company that is revolutionizing the field of diagnostic testing and personalized medicine. Founded in 2018, Talis is headquartered in Menlo Park, California, and is dedicated to improving healthcare outcomes by providing accurate, rapid, and actionable diagnostic solutions.
The company's core mission is to empower patients and healthcare providers with the ability to make informed decisions quickly and effectively. To achieve this, Talis combines expertise in molecular biology, microfluidics, and data analytics to develop advanced diagnostic platforms that are both user-friendly and versatile.
One of Talis' most significant achievements is the development of the Talis One™ platform, a compact and portable diagnostic testing system that allows for rapid and precise on-site testing. The Talis One™ platform integrates molecular biology, microfluidics, and biochemistry to enable highly sensitive and specific detection of a wide range of pathogens, genetic markers, and biomarkers.
This groundbreaking technology has the potential to transform healthcare delivery by enabling faster and more accurate diagnoses, especially in remote or resource-limited settings. With the Talis One™ platform, healthcare providers can accurately identify infectious diseases, genetic disorders, and other medical conditions within a matter of minutes, enabling prompt initiation of appropriate treatment and improving patient outcomes.
In addition to the Talis One™ platform, the company also offers a range of diagnostic tests and panels for various applications. These tests cover a wide range of diseases, including respiratory infections, sexually transmitted infections, oncology, and infectious diseases. Talis' tests are designed to be highly sensitive, specific, and easy to use, making them suitable for a variety of healthcare settings.
Talis puts a strong emphasis on data analysis and integration, recognizing that the insights derived from diagnostic testing can be maximized through comprehensive data analysis. The company employs advanced algorithms and machine learning techniques to extract meaningful insights from the test results, facilitating personalized medicine and precision healthcare.
Furthermore, Talis prioritizes research and development, investing in continuous innovation and technological advancements. The company has a talented team of scientists, engineers, and bioinformatics experts who work tirelessly to improve existing products and develop new technologies. Talis also collaborates with academic institutions, research organizations, and healthcare providers to advance the field of diagnostic testing and personalized medicine.
Overall, Talis Biomedical Corporation is at the forefront of diagnostic innovation, striving to improve healthcare outcomes through rapid and accurate diagnostic testing. With its groundbreaking Talis One™ platform and commitment to research and development, Talis is poised to make a significant impact on the future of medicine.
The company's core mission is to empower patients and healthcare providers with the ability to make informed decisions quickly and effectively. To achieve this, Talis combines expertise in molecular biology, microfluidics, and data analytics to develop advanced diagnostic platforms that are both user-friendly and versatile.
One of Talis' most significant achievements is the development of the Talis One™ platform, a compact and portable diagnostic testing system that allows for rapid and precise on-site testing. The Talis One™ platform integrates molecular biology, microfluidics, and biochemistry to enable highly sensitive and specific detection of a wide range of pathogens, genetic markers, and biomarkers.
This groundbreaking technology has the potential to transform healthcare delivery by enabling faster and more accurate diagnoses, especially in remote or resource-limited settings. With the Talis One™ platform, healthcare providers can accurately identify infectious diseases, genetic disorders, and other medical conditions within a matter of minutes, enabling prompt initiation of appropriate treatment and improving patient outcomes.
In addition to the Talis One™ platform, the company also offers a range of diagnostic tests and panels for various applications. These tests cover a wide range of diseases, including respiratory infections, sexually transmitted infections, oncology, and infectious diseases. Talis' tests are designed to be highly sensitive, specific, and easy to use, making them suitable for a variety of healthcare settings.
Talis puts a strong emphasis on data analysis and integration, recognizing that the insights derived from diagnostic testing can be maximized through comprehensive data analysis. The company employs advanced algorithms and machine learning techniques to extract meaningful insights from the test results, facilitating personalized medicine and precision healthcare.
Furthermore, Talis prioritizes research and development, investing in continuous innovation and technological advancements. The company has a talented team of scientists, engineers, and bioinformatics experts who work tirelessly to improve existing products and develop new technologies. Talis also collaborates with academic institutions, research organizations, and healthcare providers to advance the field of diagnostic testing and personalized medicine.
Overall, Talis Biomedical Corporation is at the forefront of diagnostic innovation, striving to improve healthcare outcomes through rapid and accurate diagnostic testing. With its groundbreaking Talis One™ platform and commitment to research and development, Talis is poised to make a significant impact on the future of medicine.
Talis Biomedical Corporation specializes in the development and commercialization of diagnostic testing products, particularly in the field of infectious diseases. Founded with the goal of creating rapid, accurate, and accessible diagnostic solutions, Talis focuses on delivering advanced molecular testing technologies.
Segments
1. Molecular Diagnostics: This is the primary segment where Talis Biomedical operates. The focus is on developing diagnostic tests that utilize molecular biology techniques to detect pathogens through their genetic material. This segment utilizes various technologies to provide rapid results.
2. Infectious Disease Testing: Within molecular diagnostics, the company emphasizes infectious diseases, particularly sexually transmitted infections (STIs) and respiratory pathogens. This segment addresses the critical need for swift and reliable testing solutions to improve patient outcomes and control outbreaks.
3. Point-of-Care Testing: Talis is dedicated to Point-of-Care (POC) diagnostics, enabling testing to be conducted at or near the site of patient care. This facilitates quicker decision-making, allowing for immediate treatment options which is especially crucial in acute settings.
4. Laboratory Services: Talis Biomedical may also engage in collaborations with clinical laboratories to provide comprehensive testing services. This segment ensures broader access to their diagnostic products and services, especially in areas requiring specialized testing processes.
Products
1. Talis One™: The flagship product of Talis Biomedical Corporation, Talis One is a rapid, POC diagnostic platform that provides near real-time results for a panel of infections. It utilizes advanced molecular techniques to ensure high sensitivity and specificity in detecting specific pathogens, significantly enhancing the speed of diagnosis and subsequent patient management.
- Testing Panels: Within the Talis One platform, different testing panels are available for various infections, including those for STIs like Chlamydia and Gonorrhea, as well as respiratory pathogens like Influenza and COVID-19. Each panel is designed to deliver results quickly, typically within an hour, and helps clinicians make informed decisions on treatment.
2. Assay Development: Talis engages in the research and development of new assays to expand their product offerings. These assays are designed to adapt to emerging infectious threats and evolving healthcare demands, ensuring that Talis remains a relevant player in the diagnostic space.
3. Software Integration: Talis Biomedical incorporates software solutions with their diagnostic products, enabling data management and result reporting functionalities. These tools facilitate streamlined workflows for healthcare providers and improve the overall user experience.
Services
1. Clinical Trials and Research Services: Talis Biomedical is involved in extensive clinical research to validate their products and expand their diagnostic capabilities. They conduct trials to assess the efficiency, accuracy, and clinical utility of their tests, ensuring compliance with regulatory standards.
2. Technical Support and Training: To maximize the use of Talis products, the company offers training and technical support services to healthcare providers and laboratories. This ensures users are proficient in operating their systems and interpreting results accurately.
3. Partnerships and Collaborations: Talis actively seeks partnerships with healthcare organizations, research institutions, and laboratories to broaden the availability of their testing solutions. By collaborating, they aim to enhance public health response capabilities and improve diagnostic testing accessibility.
In summary, Talis Biomedical Corporation focuses on innovating molecular diagnostic solutions tailored to infectious diseases. With a robust lineup of products designed for rapid testing and associated supportive services, Talis aims to enhance patient care and healthcare provider效率. Their commitment to research, development, and strategic partnerships positions them as a leader in the field of molecular diagnostics.
Segments
1. Molecular Diagnostics: This is the primary segment where Talis Biomedical operates. The focus is on developing diagnostic tests that utilize molecular biology techniques to detect pathogens through their genetic material. This segment utilizes various technologies to provide rapid results.
2. Infectious Disease Testing: Within molecular diagnostics, the company emphasizes infectious diseases, particularly sexually transmitted infections (STIs) and respiratory pathogens. This segment addresses the critical need for swift and reliable testing solutions to improve patient outcomes and control outbreaks.
3. Point-of-Care Testing: Talis is dedicated to Point-of-Care (POC) diagnostics, enabling testing to be conducted at or near the site of patient care. This facilitates quicker decision-making, allowing for immediate treatment options which is especially crucial in acute settings.
4. Laboratory Services: Talis Biomedical may also engage in collaborations with clinical laboratories to provide comprehensive testing services. This segment ensures broader access to their diagnostic products and services, especially in areas requiring specialized testing processes.
Products
1. Talis One™: The flagship product of Talis Biomedical Corporation, Talis One is a rapid, POC diagnostic platform that provides near real-time results for a panel of infections. It utilizes advanced molecular techniques to ensure high sensitivity and specificity in detecting specific pathogens, significantly enhancing the speed of diagnosis and subsequent patient management.
- Testing Panels: Within the Talis One platform, different testing panels are available for various infections, including those for STIs like Chlamydia and Gonorrhea, as well as respiratory pathogens like Influenza and COVID-19. Each panel is designed to deliver results quickly, typically within an hour, and helps clinicians make informed decisions on treatment.
2. Assay Development: Talis engages in the research and development of new assays to expand their product offerings. These assays are designed to adapt to emerging infectious threats and evolving healthcare demands, ensuring that Talis remains a relevant player in the diagnostic space.
3. Software Integration: Talis Biomedical incorporates software solutions with their diagnostic products, enabling data management and result reporting functionalities. These tools facilitate streamlined workflows for healthcare providers and improve the overall user experience.
Services
1. Clinical Trials and Research Services: Talis Biomedical is involved in extensive clinical research to validate their products and expand their diagnostic capabilities. They conduct trials to assess the efficiency, accuracy, and clinical utility of their tests, ensuring compliance with regulatory standards.
2. Technical Support and Training: To maximize the use of Talis products, the company offers training and technical support services to healthcare providers and laboratories. This ensures users are proficient in operating their systems and interpreting results accurately.
3. Partnerships and Collaborations: Talis actively seeks partnerships with healthcare organizations, research institutions, and laboratories to broaden the availability of their testing solutions. By collaborating, they aim to enhance public health response capabilities and improve diagnostic testing accessibility.
In summary, Talis Biomedical Corporation focuses on innovating molecular diagnostic solutions tailored to infectious diseases. With a robust lineup of products designed for rapid testing and associated supportive services, Talis aims to enhance patient care and healthcare provider效率. Their commitment to research, development, and strategic partnerships positions them as a leader in the field of molecular diagnostics.